November 7th 2022
Expert panelists review the evolving roles of PSMA-targeted PET imaging and conventional imaging in patients with prostate cancer.
January 14th 2022
Reactions to the emergence of novel immunotherapy agents for treatment of bladder cancer, including increased administration in community urology practices, and recommendations for sequencing newer therapies into treatment algorithms.
November 30th 2021
Neal Shore, MD, FACS; Bobby Liaw, MD; Vivek K. Narayan, MD, MS; and Ashley E. Ross, MD, PhD, share key insights on advances in the use of androgen receptor inhibitors (ARIs) and discuss the urologist’s role in managing patients with mCSPC and nmCRPC.
December 19th 2019
Experts in treating prostate cancer highlight recent clinical data and discuss practical implications for patient care.